Spyre Therapeutics SYRE
NASDAQ SYRE
$104.50 +0.02 (+0.02%)
As of: Nov 11, 2026 · 11:03 AM EST

Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015)

Updated

Spyre Therapeutics (SYRE) reported Preferred Dividend Payments of $228,000 for FY2015.

Analysis

Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Spyre Therapeutics 9.40 Bn 5.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 228,000.00
API Access

Spyre Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=SYRE&period=max&api_key=YOUR_API_KEY